CompletedNot applicableNCT00149708
Consequence of Lifetime Isolated Growth Hormone Deficiency
Studying Non-acquired isolated growth hormone deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Principal Investigator
- Roberto Salvatori, MDJohns Hopkins University
- Intervention
- growth hormone administration for 6 months(drug)
- Enrollment
- 400 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2005 – 2009
Study locations (1)
- Federal University of Sergipe, Aracaju, Sergipe, Brazil
Collaborators
Genentech, Inc.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00149708 on ClinicalTrials.gov